Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
509
datasets available to search
ShareScore release 0.9.0
Dataset results
509 results for “Hepatitis C Virus”
Liver Test Study of Using JKB-122 in Hepatitis C Virus (HCV)-Positive Patients Nonresponsive to Prior Interferon Based Therapies
ClinicalTrials.gov study NCT02293941. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD)
ClinicalTrials.gov study NCT01731301. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Correlation Between Cytokines and Hepatic Histology in Patients Infected by HIV-1 and the Hepatitis-C Virus
ClinicalTrials.gov study NCT00499434. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TMC649128HPC1002 - a Trial inGenotype 1 Hepatitis C Virus (HCV) - Infected Participants to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of TMC649128, Alone and Combined
ClinicalTrials.gov study NCT01391117. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Impact of Interferon-free Treatment for Hepatitis C Virus (HCV) on Blood Cells and Factors in Blood
ClinicalTrials.gov study NCT02718573. IPD Sharing: YES. Countries: 1. Publications: 0.
Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03109457. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Impact of Hepatitis C Virus Variability on Steatosis
ClinicalTrials.gov study NCT00843076. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacogenomics Study on IL28B Genetic Variants in Chinese Children With Hepatitis C Virus Infection
ClinicalTrials.gov study NCT01607021. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Use-Results Surveillance Study of Sovaldi® Plus Rebetol® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection
ClinicalTrials.gov study NCT02562742. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ISIS 14803-CS2, Treatment With ISIS 14803, Administered IV in Patients With Chronic Hepatitis C Virus Infections
ClinicalTrials.gov study NCT00035945. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection
ClinicalTrials.gov study NCT00164073. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Ravidasvir in Combination With Danoprevir/r and Ribavirin(RBV) in Treatment-naive, Non-cirrhotic, Chronic Hepatitis C Virus Genotype1 Infected Subjects.
ClinicalTrials.gov study NCT03362814. IPD Sharing: NO. Countries: 1. Publications: 0.
A Randomized, Open-Label Study of Daclatasvir and Sofosbuvir With or Without Ribavirin for 8 Weeks in Treatment-Naïve, Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus (HCV) Genotype 3
ClinicalTrials.gov study NCT02551861. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Multiple Ascending Dose Study of BMS-929075 in Hepatitis C Virus (HCV) Infected Patients
ClinicalTrials.gov study NCT01525212. IPD Sharing: Not stated. Countries: 1. Publications: 0.
GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) Infection
ClinicalTrials.gov study NCT01353248. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study of Bavituximab in Patients With Chronic Hepatitis C Virus Infection
ClinicalTrials.gov study NCT00128271. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either
ClinicalTrials.gov study NCT02397395. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study to Determine the Hepatitis C Virus Infection Prevalence Among Patients Attended Primarily for Vasculitis
ClinicalTrials.gov study NCT03693586. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of a Novel Therapeutic Vaccine for Hepatitis C Virus
ClinicalTrials.gov study NCT01094873. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial to Evaluate Safety, Tolerability, PK and Antiviral Activity of MB-110 in Hepatitis C Virus Infected Patients
ClinicalTrials.gov study NCT02617615. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.